Mirum Pharmaceuticals, Inc.
MIRM- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001759425
In the last 90 days, Mirum Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 9 sales; 326 institutions reported holding it in 13F filings for Q2 2026, worth $8.36B in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Mirum Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 112 | 1 | 104 | −7 |
| Shares | 33.7M | 780 | 33.3M | −411.2K (−1.2%) |
| Value | $709.1M | $16.0K | $650.2M | −$58.8M (−8.3%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (16)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 339,510 | $6.62M | 0.03% |
| Stonepine Capital Management, LLC | 108,769 | $2.12M | 0.89% |
| Renaissance Technologies LLC | 93,300 | $1.82M | 0.00% |
| CenterBook Partners LP | 54,464 | $1.06M | 0.17% |
| Secure Asset Management, LLC | 43,172 | $841.9K | 0.30% |
| Affinity Asset Advisors, LLC | 40,000 | $780.0K | 0.36% |
| Voloridge Investment Management, LLC | 24,989 | $487.3K | 0.00% |
| UBS Asset Management Americas Inc | 20,164 | $393.2K | 0.00% |
| Squarepoint Ops LLC | 15,117 | $294.8K | 0.00% |
| Mirae Asset Global Investments Co., Ltd. | 10,145 | $197.8K | 0.00% |
| Leonteq Securities AG | 5,000 | $97.5K | 0.01% |
| Lindbrook Capital, LLC | 237 | $4.62K | 0.00% |
| US Bancorp | 140 | $2.73K | 0.00% |
| Signaturefd, LLC | 23 | $449 | 0.00% |
| Gradient Investments LLC | 18 | $351 | 0.00% |
| Nisa Investment Advisors, LLC | 23 | $0 | 0.00% |
Sold out (23)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Victory Capital Management Inc | 694,364 | $14.6M |
| First Light Asset Management, LLC | 522,864 | $11.0M |
| OrbiMed Advisors LLC | 521,891 | $11.0M |
| Soleus Capital Management, L.P. | 135,618 | $2.85M |
| Calamos Advisors LLC | 108,653 | $2.28M |
| Prudential Financial Inc | 105,335 | $2.21M |
| MPM Oncology Impact Management LP | 97,322 | $2.04M |
| Integral Health Asset Management, LLC | 50,000 | $1.05M |
| Two Sigma Investments, LP | 47,748 | $1.00M |
| D. E. Shaw & Co., Inc. | 36,145 | $759.0K |
| Monashee Investment Management LLC | 30,000 | $630.0K |
| Algert Global LLC | 22,805 | $479.0K |
| New York Life Investments Alternatives | 20,032 | $421.0K |
| Los Angeles Capital Management LLC | 17,533 | $368.0K |
| Connor, Clark & Lunn Investment Management Ltd. | 10,689 | $225.0K |
| STRS Ohio | 10,200 | $214.0K |
| Aquatic Capital Management LLC | 7,000 | $147.0K |
| High Net Worth Advisory Group LLC | 1,500 | $32.0K |
| Wells Fargo & Company | 737 | $16.0K |
| Almanack Investment Partners, LLC. | 634 | $13.0K |
| CWM, LLC | 42 | $1.00K |
| Ellevest, Inc. | 8 | $0 |
| Covestor Ltd | 1 | $0 |
Not filed for Q4 2022 yet (1)
Institutions that held Mirum Pharmaceuticals, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| FourThought Financial, LLC | 780 | $16.0K |